Annual Debt To Equity
0.00
-0.41-100.00%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual debt to equity ratio is currently 0.00, with the most recent change of -0.41 (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -2.05 (-100.00%). EYPT annual debt to equity is now -100.00% below its all-time high of 5.67, reached on 31 December 2019.EYPT Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
0.00
0.000.00%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly debt to equity ratio is currently 0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.EYPT quarterly debt to equity is now -100.00% below its all-time high of 12.00, reached on 30 June 2020.EYPT Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
EYPT Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
EyePoint Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 0.00(0.0%) |
| June 2024 | - | 0.00(0.0%) |
| Mar 2024 | - | 0.00(0.0%) |
| Dec 2023 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2023 | - | 0.00(0.0%) |
| June 2023 | - | 0.00(-100.0%) |
| Mar 2023 | - | 0.44(+7.3%) |
| Dec 2022 | 0.41(+105.0%) | 0.41(+41.4%) |
| Sept 2022 | - | 0.29(+11.5%) |
| June 2022 | - | 0.26(+8.3%) |
| Mar 2022 | - | 0.24(+20.0%) |
| Dec 2021 | 0.20(-90.2%) | 0.20(-48.7%) |
| Sept 2021 | - | 0.39(+14.7%) |
| June 2021 | - | 0.34(+3.0%) |
| Mar 2021 | - | 0.33(-83.9%) |
| Dec 2020 | 2.05(-63.8%) | 2.05(-69.4%) |
| Sept 2020 | - | 6.69(-44.3%) |
| June 2020 | - | 12.00(+313.8%) |
| Mar 2020 | - | 2.90(-48.9%) |
| Dec 2019 | 5.67(+1106.4%) | 5.67(+93.5%) |
| Sept 2019 | - | 2.93(+78.7%) |
| June 2019 | - | 1.64(+1.9%) |
| Mar 2019 | - | 1.61(+335.1%) |
| Dec 2018 | 0.47(-68.2%) | - |
| Sept 2018 | - | 0.37(-75.0%) |
| June 2018 | 1.48(>+9900.0%) | 1.48(-5.7%) |
| Mar 2018 | - | 1.57(>+9900.0%) |
| Dec 2017 | - | 0.00(0.0%) |
| Sept 2017 | - | 0.00(0.0%) |
| June 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | - | 0.00(0.0%) |
| Sept 2016 | - | 0.00(0.0%) |
| June 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | - | 0.00(0.0%) |
| Sept 2015 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | - | 0.00(0.0%) |
| Sept 2014 | - | 0.00(0.0%) |
| June 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | - | 0.00(0.0%) |
| Sept 2013 | - | 0.00(0.0%) |
| June 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2013 | - | 0.00(0.0%) |
| Dec 2012 | - | 0.00(0.0%) |
| Sept 2012 | - | 0.00(0.0%) |
| June 2012 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2012 | - | 0.00(0.0%) |
| Dec 2011 | - | 0.00(0.0%) |
| Sept 2011 | - | 0.00(0.0%) |
| June 2011 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2011 | - | 0.00(0.0%) |
| Sept 2010 | - | 0.00(0.0%) |
| June 2010 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2010 | - | 0.00(0.0%) |
| Dec 2009 | - | 0.00(0.0%) |
| Sept 2009 | - | 0.00(0.0%) |
| June 2009 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2009 | - | 0.00(0.0%) |
| Dec 2008 | - | 0.00(0.0%) |
| Sept 2008 | - | 0.00(0.0%) |
| June 2008 | 0.00(0.0%) | 0.00(0.0%) |
| Mar 2008 | - | 0.00(0.0%) |
| Dec 2007 | - | 0.00(0.0%) |
| Sept 2007 | - | 0.00(0.0%) |
| June 2007 | 0.00(-100.0%) | 0.00(-100.0%) |
| Dec 2006 | - | 0.14(+55.6%) |
| June 2006 | 0.09(>+9900.0%) | 0.09(>+9900.0%) |
| June 2005 | 0.00(0.0%) | 0.00(0.0%) |
| June 2004 | 0.00(0.0%) | 0.00(0.0%) |
| June 2003 | 0.00(-100.0%) | 0.00 |
| June 2001 | 0.03 | - |
FAQ
- What is EyePoint Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual debt to equity year-on-year change?
- What is EyePoint Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly debt to equity year-on-year change?
What is EyePoint Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of EYPT is 0.00
What is the all time high annual debt to equity for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual debt to equity ratio is 5.67
What is EyePoint Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, EYPT annual debt to equity ratio has changed by -0.41 (-100.00%)
What is EyePoint Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of EYPT is 0.00
What is the all time high quarterly debt to equity for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly debt to equity ratio is 12.00
What is EyePoint Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, EYPT quarterly debt to equity ratio has changed by 0.00 (0.00%)